ArticleJournal of translational medicine2025

Lipocalin-2 promotes NSCLC progression by activating the JAK2/STAT3 signaling pathway.

Jinjin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.